Drug stocks are split in early trading Friday as shares of BioCryst Pharmaceuticals rocket on positive Phase III results for its flu-fighting treatment.
MarketWatch.com - Top Stories, MarketWatch
Fri, 07/17/2009 - 7:45am
Drug stocks are split in early trading Friday as shares of BioCryst Pharmaceuticals rocket on positive Phase III results for its flu-fighting treatment.